AILETTE LOPEZ BOUDET: Open Payments
NPI 1043798176 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,153 in 55 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,917 · 2025 $1,153
Food & beverage: $1,153
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $195 |
| AstraZeneca Pharmaceuticals LP | 6 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $134 |
| Corcept Therapeutics | 5 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| PFIZER INC. | 4 | $79 |
| Lilly USA, LLC | 4 | $76 |
| ABBVIE INC. | 2 | $39 |
| Ardelyx, Inc. | 2 | $37 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
Products named: JARDIANCE, Korlym, Kerendia, Ozempic, ELIQUIS, Wegovy, Rybelsus, FARXIGA.
Industry payments across FL — which companies pay providers there.
